Search

Your search keyword '"Neural Tube Defects metabolism"' showing total 433 results

Search Constraints

Start Over You searched for: Descriptor "Neural Tube Defects metabolism" Remove constraint Descriptor: "Neural Tube Defects metabolism"
433 results on '"Neural Tube Defects metabolism"'

Search Results

1. High Homocysteine-Thiolactone Leads to Reduced MENIN Protein Expression and an Impaired DNA Damage Response: Implications for Neural Tube Defects.

2. The interaction of endorepellin and neurexin triggers neuroepithelial autophagy and maintains neural tube development.

3. Zinc oxide nanoparticles induces cell death and consequently leading to incomplete neural tube closure through oxidative stress during embryogenesis.

4. Association of embryonic inositol status with susceptibility to neural tube defects, metabolite profile, and maternal inositol intake.

5. RSG1 is required for cilia-dependent neural tube closure.

6. Activation of lipophagy ameliorates cadmium-induced neural tube defects via reducing low density lipoprotein cholesterol levels in mouse placentas.

7. Pin1 Downregulation Is Involved in Excess Retinoic Acid-Induced Failure of Neural Tube Closure.

8. Optical coherence tomography-guided Brillouin microscopy highlights regional tissue stiffness differences during anterior neural tube closure in the Mthfd1l murine mutant.

9. Perspectives on folate with special reference to epigenetics and neural tube defects.

10. Prenatal cadmium exposure impairs neural tube closure via inducing excessive apoptosis in neuroepithelium.

11. Loss of SHROOM3 affects neuroepithelial cell shape through regulating cytoskeleton proteins in cynomolgus monkey organoids.

12. Noncanonical function of folate through folate receptor 1 during neural tube formation.

13. On the genetic basis of tail-loss evolution in humans and apes.

14. Folate regulation of planar cell polarity pathway and F-actin through folate receptor alpha.

15. Folate deficiency reduced aberrant level of DOT1L-mediated histone H3K79 methylation causes disruptive SHH gene expression involved in neural tube defects.

16. An optimal combination of five main monomer components in Wuzi Yanzong Pill that prevents neural tube defects and reduces apoptosis and oxidative stress.

17. Spatiotemporal protein dynamics during early organogenesis in mouse conceptuses treated with valproic acid.

18. Maternal metabolism influences neural tube closure.

19. MTHFD1 is critical for the negative regulation of retinoic acid receptor signalling in anencephaly.

20. TMEM132A regulates mouse hindgut morphogenesis and caudal development.

21. Loss-of-Function of p21-Activated Kinase 2 Links BMP Signaling to Neural Tube Patterning Defects.

22. Understanding the Role of ATP Release through Connexins Hemichannels during Neurulation.

23. Polymorphisms of Placental Iodothyronine Deiodinase Genes in a Rural Area of Northern China with High Prevalence of Neural Tube Defects.

24. Inhibition of retinoic acid signaling impairs cranial and spinal neural tube closure in mice lacking the Grainyhead-like 3 transcription factor.

25. Wnt/planar cell polarity signaling controls morphogenetic movements of gastrulation and neural tube closure.

26. TMEM132A ensures mouse caudal neural tube closure and regulates integrin-based mesodermal migration.

27. Mitochondrial FAD shortage in SLC25A32 deficiency affects folate-mediated one-carbon metabolism.

28. Expanding the clinical phenotype of FGFR1 internal tandem duplication.

29. Hypermethylation of PI3K-AKT signalling pathway genes is associated with human neural tube defects.

30. NRF2 activation inhibits valproic acid-induced neural tube defects in mice.

31. Nuclear factor I-C disrupts cellular homeostasis between autophagy and apoptosis via miR-200b-Ambra1 in neural tube defects.

32. Valproic acid promotes SOD2 acetylation: a potential mechanism of valproic acid-induced oxidative stress in developing systems.

33. Unraveling the complex genetics of neural tube defects: From biological models to human genomics and back.

34. Micronutrient imbalance and common phenotypes in neural tube defects.

35. Okadaic Acid Exposure Induced Neural Tube Defects in Chicken ( Gallus gallus ) Embryos.

36. The effect of folic acid deficiency on Mest/Peg1 in neural tube defects.

37. Structural basis of the human Scribble-Vangl2 association in health and disease.

38. Organoids as a new model system to study neural tube defects.

39. Aberrant Gcm1 expression mediates Wnt/β-catenin pathway activation in folate deficiency involved in neural tube defects.

40. Does C-C Motif Chemokine Ligand 2 (CCL2) Link Obesity to a Pro-Inflammatory State?

41. Loss-of-function or gain-of-function variations in VINCULIN (VCL) are risk factors of human neural tube defects.

42. Gestational folate deficiency alters embryonic gene expression and cell function.

43. Characterizing the effects of in utero valproic acid exposure on NF-κB signaling in CD-1 mouse embryos during neural tube closure.

44. The Evaluation of Survivin and Bcl-2 Expression on the Medical Radiation Doses for Neural Tube Defect Development.

45. Deficiency of the oxidative stress-responsive kinase p70S6K1 restores autophagy and ameliorates neural tube defects in diabetic embryopathy.

46. Restoring BMP4 expression in vascular endothelial progenitors ameliorates maternal diabetes-induced apoptosis and neural tube defects.

48. Somatic mutations in planar cell polarity genes in neural tissue from human fetuses with neural tube defects.

49. Identification of histone malonylation in the human fetal brain and implications for diabetes-induced neural tube defects.

50. Amniotic fluid levels of selected trace elements and heavy metals in pregnancies complicated with neural tube defects.

Catalog

Books, media, physical & digital resources